Yifeng Pharmacy Chain Co., Ltd.

Shanghai Stock Exchange 603939.SS

Yifeng Pharmacy Chain Co., Ltd. Free Cash Flow for the year ending December 31, 2023: USD 547.04 M

Yifeng Pharmacy Chain Co., Ltd. Free Cash Flow is USD 547.04 M for the year ending December 31, 2023, a 13.27% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
  • Yifeng Pharmacy Chain Co., Ltd. Free Cash Flow for the year ending December 31, 2022 was USD 482.95 M, a 132.05% change year over year.
  • Yifeng Pharmacy Chain Co., Ltd. Free Cash Flow for the year ending December 31, 2021 was USD 208.12 M, a 80.45% change year over year.
  • Yifeng Pharmacy Chain Co., Ltd. Free Cash Flow for the year ending December 31, 2020 was USD 115.34 M, a 57.74% change year over year.
  • Yifeng Pharmacy Chain Co., Ltd. Free Cash Flow for the year ending December 31, 2019 was USD 73.12 M, a 81.52% change year over year.
Key data
Date Free Cash Flow Operating Cash Flow Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities
Market news
Loading...
Shanghai Stock Exchange: 603939.SS

Yifeng Pharmacy Chain Co., Ltd.

CEO Mr. Gao Yi
IPO Date Feb. 17, 2015
Location China
Headquarters Yifeng Medical Park
Employees 39,652
Sector Health Care
Industries
Description

Yifeng Pharmacy Chain Co., Ltd. retails pharmaceutical products in China. As of March 31, 2021, it operates approximately 6,279 pharmaceutical chain stores in Hunan, Hubei, Shanghai, Jiangsu, Zhejiang, Jiangxi, Guangdong, Hebei, and Beijing. The company was founded in 2001 and is based in Changsha, China.

Similar companies

603899.SS

Shanghai M&G Stationery Inc.

USD 3.92

1.92%

603233.SS

DaShenLin Pharmaceutical Group Co., Ltd.

USD 1.93

2.10%

603883.SS

LBX Pharmacy Chain Joint Stock Company

USD 2.19

4.03%

600763.SS

Topchoice Medical Corporation

USD 5.73

2.34%

603882.SS

Guangzhou Kingmed Diagnostics Group Co., Ltd.

USD 3.54

2.01%

StockViz Staff

January 15, 2025

Any question? Send us an email